PATENT CLAIM ANALYSIS

Application Number: 16254208
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "318000"]

Abstract:
Provided herein are aminopyridine derivatives and pharmaceutical compositions that are useful as TAM family kinase inhibitors.

Claim (Index 16):
A method of treating restenosis comprising administering to a subject in need thereof a pharmaceutically effective amount of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.0625
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15039609', '12138251', '15971017', '15521202', '10541657']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7413646697251672
- 35 USC 102 Novelty (BERT): 0.6245255189302166
- Combined Prediction Score: 0.7296807546456722
- Mean Citation Score: 376.019402
- Max Citation Score: 685.8925
- Similarity Product: 485.72525977998976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test